The Fellow on Call is thrilled to partner with so many of our podcasting friends be a part of #NephMadness 2023 this year. In today’s episode, we welcome three incredible guests to our show, Dr. Matthew Abramson, Dr. Timothy Yau, and Dr. Scott Stockholm, to talk about the two very critical topics in hematology/oncology. The first is a discussion about immune checkpoint inhibitor-related AKIs. The second is a discussion about hypomagnesia in our patients. To learn more about NephMadness and to cast your votes, be sure to check out: https://ajkdblog.org/tag/nephmadness2023/. We’d love to see Onconephrology snag that #1 spot :) Content:- What is the mechanism of immune checkpoint inhibitor-associated AKIs? - What is the etiology of ICI-related AKIs? - How do we work these up? - How do we treat? Steroids? Do we biopsy?- Can we re-trial ICI in someone who had ICI-related AKI?- How do we use ICI in patients with kidney transplants? - What are symptoms of hypomagnesemia? - A refresher on magnesium homeostasis - How do we manage hypomagnesemia? - What drugs are associated with hypomagnesemia? **A huge thank you to Dr. Joel Topf and the team at NephMadness for the invitation to be a part of this podcrawl, helping to collect resources, and create a show outline** A huge thank you to our guests!** Help us as we continue to grow our show by filling out this BRIEF survey! Link: https://forms.gle/KBhDRTGBqRJ1CgnK7Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodesLove what you hear? Tell a friend and leave a review on our podcast streaming platforms!Twitter: @TheFellowOnCallInstagram: @TheFellowOnCallListen in on: Apple Podcast, Spotify, and Google Podcast

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.